Wall Street brokerages predict that Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) will post sales of $698.02 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Calumet Specialty Products Partners, L.P’s earnings, with estimates ranging from $680.00 million to $716.03 million. Calumet Specialty Products Partners, L.P reported sales of $883.80 million during the same quarter last year, which suggests a negative year over year growth rate of 21%. The company is expected to issue its next earnings report on Thursday, March 14th.

On average, analysts expect that Calumet Specialty Products Partners, L.P will report full-year sales of $3.35 billion for the current financial year, with estimates ranging from $3.33 billion to $3.37 billion. For the next financial year, analysts forecast that the firm will post sales of $3.00 billion, with estimates ranging from $2.97 billion to $3.03 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that that provide coverage for Calumet Specialty Products Partners, L.P.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last issued its earnings results on Friday, November 9th. The oil and gas company reported ($0.09) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.13) by $0.04. The business had revenue of $953.50 million for the quarter, compared to the consensus estimate of $794.60 million. Calumet Specialty Products Partners, L.P had a negative net margin of 3.90% and a negative return on equity of 45.78%.

Several analysts recently commented on CLMT shares. ValuEngine upgraded shares of Calumet Specialty Products Partners, L.P from a “sell” rating to a “hold” rating in a research note on Saturday, October 27th. BidaskClub cut shares of Calumet Specialty Products Partners, L.P from a “hold” rating to a “sell” rating in a research note on Friday, September 7th. Zacks Investment Research cut shares of Calumet Specialty Products Partners, L.P from a “buy” rating to a “hold” rating in a research note on Wednesday, October 10th. Finally, Cowen set a $5.00 price objective on shares of Calumet Specialty Products Partners, L.P and gave the company a “hold” rating in a research note on Wednesday, November 28th.

Shares of NASDAQ:CLMT traded down $0.08 during midday trading on Friday, hitting $3.08. The stock had a trading volume of 336,581 shares, compared to its average volume of 404,603. The company has a market cap of $233.75 million, a price-to-earnings ratio of -5.50 and a beta of 1.49. The company has a quick ratio of 0.71, a current ratio of 1.41 and a debt-to-equity ratio of 41.13. Calumet Specialty Products Partners, L.P has a 1 year low of $2.94 and a 1 year high of $9.35.

In other Calumet Specialty Products Partners, L.P news, EVP A Anderson William bought 11,600 shares of the business’s stock in a transaction on Monday, November 19th. The stock was bought at an average price of $3.59 per share, for a total transaction of $41,644.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David West Griffin bought 7,000 shares of the business’s stock in a transaction on Thursday, September 13th. The shares were acquired at an average price of $6.55 per share, with a total value of $45,850.00. Following the transaction, the chief financial officer now owns 88,904 shares of the company’s stock, valued at approximately $582,321.20. The disclosure for this purchase can be found here. Insiders purchased 33,055 shares of company stock valued at $179,851 in the last quarter. Company insiders own 4.75% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. Eqis Capital Management Inc. acquired a new position in Calumet Specialty Products Partners, L.P during the second quarter worth about $118,000. Stratos Wealth Partners LTD. acquired a new position in Calumet Specialty Products Partners, L.P during the third quarter worth about $148,000. OppenheimerFunds Inc. acquired a new position in Calumet Specialty Products Partners, L.P during the second quarter worth about $298,000. Sumitomo Mitsui Trust Holdings Inc. raised its position in Calumet Specialty Products Partners, L.P by 87.0% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 43,000 shares of the oil and gas company’s stock worth $320,000 after acquiring an additional 20,000 shares during the last quarter. Finally, Creative Planning raised its position in Calumet Specialty Products Partners, L.P by 199.3% during the third quarter. Creative Planning now owns 55,565 shares of the oil and gas company’s stock worth $356,000 after acquiring an additional 37,000 shares during the last quarter. Institutional investors own 14.06% of the company’s stock.

Calumet Specialty Products Partners, L.P Company Profile

Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America and internationally. It operates in two segments, Specialty Products and Fuel Products. The Specialty Products segment offers various lubricating oils, white mineral oils, solvents, petrolatums, waxes, synthetic lubricants, and other products which are used primarily as raw material components for basic automotive, industrial, and consumer goods.

Featured Story: Marijuana Stocks

Get a free copy of the Zacks research report on Calumet Specialty Products Partners, L.P (CLMT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Calumet Specialty Products Partners L.P Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners L.P and related companies with MarketBeat.com's FREE daily email newsletter.